First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial.

Anne Hansen ReeJūratė Šaltytė BenthHanne M HamreChristian KerstenEva HofsliMarianne G GurenHalfdan SorbyeChristin JohansenAnne NegårdTonje BjørnetrøHilde L NilsenJens P BergKjersti FlatmarkSebastian Meltzer

Published in: British journal of cancer (2024)

ClinicalTrials.gov number, NCT03388190 (02/01/2018).

Keyphrases

study protocol
clinical trial
open label
phase iii
phase ii
squamous cell carcinoma
double blind
small cell lung cancer
placebo controlled
locally advanced
randomized controlled trial
genetic diversity
chemotherapy induced
rectal cancer